510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

Allergen Immundocap MODELC5, C6, C73, E201, E213, F50, F51,F54, F55, F56, F57, F58, F59, F60, F61, F205, F213, F218, F

K993388510(k) TraditionalCleared Dec 1, 199954-day reviewClass II21 CFR 866.5750Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pharmacia & Upjohn Co. · DHB System, Test, Radioallergosorbent (Rast) Immunological

Cleared on Dec 1, 1999 as substantially equivalent to K894190 (Pharmacia, Inc., 1990) and 2 other predicates after a 54-day review. Its family tree reaches back 1 generation to 1990. It has been recalled 2 times.

Decided
Dec 1, 1999
Review
54 days
Class
Class II
Product code
DHB
Recalls
2
Predicates
3

Its longest line of descent runs back 1 generation to K894190 (1990). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1996: 1 other ancestor1991: 1 other ancestorK894190 · Pharmacia Cap System Rast Ria & Rast Feia · Pharmacia, Inc. · 1990199019921994199619982000
Other ancestors, by generation 1 generation back: 2 other ancestors K894190 · Pharmacia Cap System Rast Ria & Rast Feia · Pharmacia, Inc. · 19900
  1. Root · 1 generation backK894190 Pharmacia Cap System Rast Ria & Rast FeiaPharmacia, Inc. · 1990
  2. This deviceK993388 Allergen Immundocap MODELC5, C6, C73, E201, E213, F50, F51,F54, F55…Pharmacia & Upjohn Co. · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K894190Pharmacia Cap System Rast Ria & Rast FeiaPharmacia, Inc.1990—
0 (this device)K993388Allergen Immundocap MODELC5, C6, C73, E201, E213, F50, F51,F54, F55, F56, F57…Pharmacia & Upjohn Co.1999—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
FIG. 1 — Lineage of K993388, 1990–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DHB device

  1. #1 K260331 IMMULITE 2000 3gAllergy Specific IgE Vantage…score 12.3 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K894190Pharmacia Cap System Rast Ria & Rast Feia
Summary page 2
…2, £233, {244, £254, £299, £x7, £x13, £x14, fx15, 18, £20, g201, gx3, gx4, 18,173, 1201, m207, ol, p4, 1208, tx6, tx9, wx3 Predi ¢ f i D Pharmacia CAP System™ RAST FEIA K894190, K911903 UniCAP™ Specific IgE Assay K962274 Intepded Use Statement : Allergen JmmunoCAP™ is the solid phase component of the P…
Pharmacia, Inc.1990—
*K911903Allergans Pharmacia Cap Sys.Rast Ria/Feia
Summary page 2
…{244, £254, £299, £x7, £x13, £x14, fx15, 18, £20, g201, gx3, gx4, 18,173, 1201, m207, ol, p4, 1208, tx6, tx9, wx3 Predi ¢ f i D Pharmacia CAP System™ RAST FEIA K894190, K911903 UniCAP™ Specific IgE Assay K962274 Intepded Use Statement : Allergen JmmunoCAP™ is the solid phase component of the Pharmacia…
Pharmacia, Inc.1991—
*K962274Unicap 100
Summary page 2
…x15, 18, £20, g201, gx3, gx4, 18,173, 1201, m207, ol, p4, 1208, tx6, tx9, wx3 Predi ¢ f i D Pharmacia CAP System™ RAST FEIA K894190, K911903 UniCAP™ Specific IgE Assay K962274 Intepded Use Statement : Allergen JmmunoCAP™ is the solid phase component of the Pharmacia & Upjohn in vitro immunodiagnostic s…
Pharmacia, Inc.1996—

Also cleared against K894190: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 18, 2017Class IIZ-1312-2018Device DesignThe stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met.
Dec 18, 2017Class IIZ-1313-2018Device DesignThe stability specifications of ImmunoCAP Allergen c6, Amoxicilloyl were not met.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 3 ancestors has a recall.
  • 2 other devices also cite its predicate K894190.

How does its category compare?

All DHB devices

DHB System, Test, Radioallergosorbent (Rast) Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DHB

2in 2025

2007: 12008: 22009: 72010: 32011: 52012: 32013: 52014: 12015: 12016: 22017: 12018: 22019: 32020: 22021: 12022: 22025: 22026 (partial year): 6
2007high 7 (2009) · low 0 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHB

90in 2019

2009: 118 days median2010: 247 days median2011: 405 days median2012: 260 days median2013: 257 days median2019: 90 days median2026 (partial year): 138 days median
2007high 405 (2011) · low 90 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DHB

14in 2025

2012: 12014: 12017: 12018: 12022: 32025: 14
2007high 14 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHB

6in 2025

2008: 12011: 12012: 22015: 12017: 112018: 62019: 42021: 72022: 12023: 62024: 102025: 6
2007high 11 (2017) · low 0 (2007)2025

MAUDE reports naming product code DHB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—01
2009711800
2010324700
2011540501
2012326012
2013525700
20141—10
20151—01
20162—00
20171—111
20182—16
201939004
20202—00
20211—07
20222—31
20230—06
20240—010
20252—146
202661380—

What is it indicated for?

Allergen ImmunoCAP™ is the solid phase component of the Pharmacia & Upjohn in vitro immunodiagnostic systems which measure specific IgE to the respective allergen bound to the ImmunoCAP. Allergen ImmunoCAP are intended to be used with Pharmacia CAP System RAST FEIA and UniCAP Specific IgE in vitro diagnostic assays.

Pharmacia CAP System RAST® FEIA and UniCAP® Specific IgE are intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other findings, and are to be used in clinical laboratories, as well as, physician office laboratories.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K993388: Allergen Immundocap MODELC5, C6, C73, E201, E213, F50, F51,F54, F55, F56, F57, F58, F59, F60, F61, F205, F213, F218, F.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K993388

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026